Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism. [electronic resource]
- EMBO reports Jan 2003
- 82-7 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1469-221X
10.1038/sj.embor.embor710 doi
Adaptor Proteins, Signal Transducing Adenocarcinoma--pathology B-Lymphocytes--drug effects Breast Neoplasms--pathology DNA--metabolism Dendritic Cells--drug effects Enzyme Activation Female HeLa Cells--drug effects Humans I-kappa B Proteins--chemistry Interleukin-1--pharmacology Lipopolysaccharides--pharmacology Lymphotoxin beta Receptor Lymphotoxin-alpha--agonists Lymphotoxin-beta Membrane Proteins--agonists NF-KappaB Inhibitor alpha NF-kappa B--metabolism NF-kappa B p52 Subunit Protein Binding--drug effects Protein Precursors--metabolism Protein Processing, Post-Translational Receptors, Tumor Necrosis Factor--agonists Recombinant Fusion Proteins--genetics Ribosomes--metabolism Sequence Deletion Tetradecanoylphorbol Acetate--pharmacology Trans-Activators--metabolism Transcription Factors Tumor Cells, Cultured--drug effects Tumor Necrosis Factor Ligand Superfamily Member 14 Tumor Necrosis Factor-alpha--pharmacology Ubiquitin--metabolism